Skip to main content
OpenTrials

Clinical trial condition

Transthyretin Amyloidosis

Explore clinical trials studying Transthyretin Amyloidosis. Study availability and eligibility vary by location and protocol.

32 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin Amyloidosis trial results

Completed

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

NCT03759379

Conditions
Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, +8 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

NCT03237494

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +20 more
Locations
  • Kepler Universitätsklinikum, Klinik für Interne 1 - Kardiologie und internistische Intensivmedizin; Cardiology Linz, Austria
  • Kepler Universitätsklinikum, Neuromed Campus; Neurology Linz, Austria
  • Universitätsklinikum Aachen, Neurology Aachen, Germany
  • Klinikum Westmünsterland GmbH, I. Medizinische Klinik und Interventionelle Kardiologie Ahaus, Germany
View all 84 locations
View Trial Details
Completed

Transthyretin Amyloidosis Outcome Survey (THAOS)

NCT00628745

Conditions
Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Metabolic Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
View all 113 locations
View Trial Details

Related conditions